Cellular Plasticity in Gut and Liver Regeneration

키워드

참고문헌 (112)

1. van der Flier LG, "Stem cells, self-renewal, and differentiation in the intestinal epithelium", Annu Rev Physiol, 71, pp.241~260 (2009)
2. Tanday N, "Pancreatic islet cell plasticity : pathogenic or therapeutically exploitable?", Diabetes Obes Metab, 26, pp.16~31 (2024)
3. Allaire JM, "The intestinal epithelium : central coordinator of mucosal immunity", Trends Immunol, 39, pp.677~696 (2018)
4. Rooks MG, "Gut microbiota, metabolites and host immunity", Nat Rev Immunol, 16, pp.341~352 (2016)
5. Mowat AM, "Regional specialization within the intestinal immune system", Nat Rev Immunol, 14, pp.667~685 (2014)
6. Gregorieff A, "Wnt signaling in the intestinal epithelium : from endoderm to cancer", Genes Dev, 19, pp.877~890 (2005)
7. Patankar JV, "Cell death in the gut epithelium and implications for chronic inflammation", Nat Rev Gastroenterol Hepatol, 17, pp.543~556 (2020)
8. Clevers H, "The intestinal crypt, a prototype stem cell compartment", Cell, 154, pp.274~284 (2013)
9. Haber AL, "A single-cell survey of the small intestinal epithelium", Nature, 551, pp.333~339 (2017)
10. Grün D, "Single-cell messenger RNA sequencing reveals rare intestinal cell types", Nature, 525, pp.251~255 (2015)
11. Hwang B, "Single-cell RNA sequencing technologies and bioinformatics pipelines", Exp Mol Med, 50, pp.1~14 (2018)
12. Olsen TK, "Introduction to single-cell RNA sequencing", Curr Protoc Mol Biol, 122, pp.e57~ (2018)
13. Barker N, "Adult intestinal stem cells : critical drivers of epithelial homeostasis and regeneration", Nat Rev Mol Cell Biol, 15, pp.19~33 (2014)
14. Tian H, "A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable", Nature, 478, pp.255~259 (2011)
15. Sangiorgi E, "Bmi1 is expressed in vivo in intestinal stem cells", Nat Genet, 40, pp.915~920 (2008)
16. Barker N, "Identification of stem cells in small intestine and colon by marker gene Lgr5", Nature, 449, pp.1003~1007 (2007)
17. Andersson-Rolf A, "Stem cells in repair of gastrointestinal epithelia", Physiology(Bethesda), 32, pp.278~289 (2017)
18. Walker MR, "The stem cell niche", J Pathol, 217, pp.169~180 (2009)
19. Yan KS, "The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations", Proc Natl Acad Sci U S A, 109, pp.466~471 (2012)
20. Meyer AR, "Injuryinduced cellular plasticity drives intestinal regeneration", Cell Mol Gastroenterol Hepatol, 13, pp.843~856 (2022)
21. de Sousa E Melo F, "Cellular plasticity in intestinal homeostasis and disease", Cell Stem Cell, 24, pp.54~64 (2019)
22. Blanpain C, "Stem cell plasticity : plasticity of epithelial stem cells in tissue regeneration", Science, 344, pp.1242281~ (2014)
23. Farin HF, "Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells", Gastroenterology, 143, pp.1518~1529 (2012)
24. Fevr T, "Wnt", beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells, 2007, pp.27, 7551~7559
25. Miyoshi H, "Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury", Science, 338, pp.108~113 (2012)
26. Bastide P, "Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium", J Cell Biol, 178, pp.635~648 (2007)
27. Mori-Akiyama Y, "SOX9 is required for the differentiation of paneth cells in the intestinal epithelium", Gastroenterology, 133, pp.539~546 (2007)
28. VanDussen KL, "Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells", Development, 139, pp.488~497 (2012)
29. Yu S, "Paneth cell multipotency induced by notch activation following injury", Cell Stem Cell, 23, pp.46~59 (2018)
30. Kosinski C, "Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors", Proc Natl Acad Sci U S A, 104, pp.15418~15423 (2007)
31. Wong VW, "Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling", Nat Cell Biol, 14, pp.401~408 (2012)
32. Clemente JC, "The impact of the gut microbiota on human health : an integrative view", Cell, 148, pp.1258~1270 (2012)
33. Kaser A, "Inflammatory bowel disease", Annu Rev Immunol, 28, pp.573~621 (2010)
34. Li B, "Impaired Wnt", β-catenin pathway leads to dysfunction of intestinal regeneration during necrotizing enterocolitis, 2019, pp.10, 743~
35. Gregorieff A, "Hippo signalling in intestinal regeneration and cancer", Curr Opin Cell Biol, 48, pp.17~25 (2017)
36. Gregorieff A, "Yap-dependent reprogramming of Lgr5(+)stem cells drives intestinal regeneration and cancer", Nature, 526, pp.715~718 (2015)
37. Yui S, "YAP", TAZ-dependent reprogramming of colonic epithelium links ECM remodeling to tissue regeneration, 2018, pp.22, 35~49
38. Barry ER, "Restriction of intestinal stem cell expansion and the regenerative response by YAP", Nature, 493, pp.106~110 (2013)
39. Kaplan GG, "The four epidemiological stages in the global evolution of inflammatory bowel disease", Nat Rev Gastroenterol Hepatol, 18, pp.56~66 (2021)
40. Park SH, "Update on the epidemiology of inflammatory bowel disease in Asia : where are we now?", Intest Res, 20, pp.159~164 (2022)
41. Mahadevan U, "Inflammatory bowel disease : Gastroenterology Diamond Jubilee review", Gastroenterology, 154, pp.1555~1558 (2018)
42. Chang JT, "Pathophysiology of inflammatory bowel diseases", N Engl J Med, 383, pp.2652~2664 (2020)
43. Okumura R, "Roles of intestinal epithelial cells in the maintenance of gut homeostasis", Exp Mol Med, 49, pp.e338~ (2017)
44. Mankertz J, "Altered permeability in inflammatory bowel disease : pathophysiology and clinical implications", Curr Opin Gastroenterol, 23, pp.379~383 (2007)
45. Na SY, "Perspectives on current and novel treatments for inflammatory bowel disease", Gut Liver, 13, pp.604~616 (2019)
46. Vulliemoz M, "TNF-alpha blockers in inflammatory bowel diseases : practical recommendations and a user's guide. An update", Digestion, 101(Suppl 1), pp.16~26 (2020)
47. Na SY, "Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors : novel biologics and small-molecule drugs", Korean J Intern Med, 37, pp.906~919 (2022)
48. Lichtenstein GR, "Importance of mucosal healing in ulcerative colitis", Inflamm Bowel Dis, 16, pp.338~346 (2010)
49. Lee SH, "Intestinal permeability regulation by tight junction : implication on inflammatory bowel diseases", Intest Res, 13, pp.11~18 (2015)
50. Hegyi P, "Guts and gall : bile acids in regulation of intestinal epithelial function in health and disease", Physiol Rev, 98, pp.1983~2023 (2018)
51. Geng H, "In inflamed intestinal tissues and epithelial cells, interleukin 22 signaling increases expression of H19 long noncoding RNA, which promotes mucosal regeneration", Gastroenterology, 155, pp.144~155 (2018)
52. Okamoto R, "Cellular and molecular mechanisms of the epithelial repair in IBD", Dig Dis Sci, 50(Suppl 1), pp.S34~S38 (2005)
53. Burt RK, "High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease", Blood, 101, pp.2064~2066 (2003)
54. Hawkey CJ, "Autologous hematopoetic stem cell transplantation for refractory Crohn disease : a randomized clinical trial", JAMA, 314, pp.2524~2534 (2015)
55. Forbes GM, "A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy", Clin Gastroenterol Hepatol, 12, pp.64~71 (2014)
56. Zhang J, "Umbilical cord mesenchymal stem cell treatment for Crohn’s disease : a randomized controlled clinical trial", Gut Liver, 12, pp.73~78 (2018)
57. Shimizu H, "Stem cellbased therapy for inflammatory bowel disease", Intest Res, 17, pp.311~316 (2019)
58. Barnhoorn MC, "Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn’s disease perianal fistulas", J Crohns Colitis, 14, pp.64~70 (2020)
59. Caplan AI, "MSCs : the sentinel and safe-guards of injury", J Cell Physiol, 231, pp.1413~1416 (2016)
60. Barnhoorn M, "Endoscopic administration of mesenchymal stromal cells reduces inflammation in experimental colitis", Inflamm Bowel Dis, 24, pp.1755~1767 (2018)
61. Sato T, "Growing self-organizing mini-guts from a single intestinal stem cell : mechanism and applications", Science, 340, pp.1190~1194 (2013)
62. Rossi G, "Progress and potential in organoid research", Nat Rev Genet, 19, pp.671~687 (2018)
63. Qi D, "Repair and regeneration of small intestine : a review of current engineering approaches", Biomaterials, 240, pp.119832~ (2020)
64. Sato T, "Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche", Nature, 459, pp.262~265 (2009)
65. Yui S, "Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+stem cell", Nat Med, 18, pp.618~623 (2012)
66. Okamoto R, "Organoid-based regenerative medicine for inflammatory bowel disease", Regen Ther, 13, pp.1~6 (2020)
67. Sato T, "Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts", Nature, 469, pp.415~418 (2011)
68. VanDussen KL, "Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays", Gut, 64, pp.911~920 (2015)
69. Maeda M, "Endoscopic cell sheet transplantation device developed by using a 3-dimensional printer and its feasibility evaluation in a porcine model", Gastrointest Endosc, 82, pp.147~152 (2015)
70. Alison M, "Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells", J Hepatol, 26, pp.343~352 (1997)
71. Evarts RP, "In vivo differentiation of rat liver oval cells into hepatocytes", Cancer Res, 49, pp.1541~1547 (1989)
72. Shin S, "Ablation of Foxl1-Cre-labeled hepatic progenitor cells and their descendants impairs recovery of mice from liver injury", Gastroenterology, 148, pp.192~202 (2015)
73. Shin S, "Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential", Genes Dev, 25, pp.1185~1192 (2011)
74. Sackett SD, "Foxl1 is a marker of bipotential hepatic progenitor cells in mice", Hepatology, 49, pp.920~929 (2009)
75. Aoki R, "Foxl1-expressing mesenchymal cells constitute the intestinal stem cell niche", Cell Mol Gastroenterol Hepatol, 2, pp.175~188 (2016)
76. Furuyama K, "Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine", Nat Genet, 43, pp.34~41 (2011)
77. Lesaffer B, "Comparison of the Opn-CreER and Ck19-CreER drivers in bile ducts of normal and injured mouse livers", Cells, 8, pp.380~ (2019)
78. Yanger K, "Robust cellular reprogramming occurs spontaneously during liver regeneration", Genes Dev, 27, pp.719~724 (2013)
79. Michalopoulos GK, "Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury", Hepatology, 41, pp.535~544 (2005)
80. Nishikawa Y, "Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro", Am J Pathol, 166, pp.1077~1088 (2005)
81. Michalopoulos GK, "Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures", Hepatology, 36, pp.278~283 (2002)
82. Limaye PB, "Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium", Hepatology, 47, pp.1702~1713 (2008)
83. Nagahama Y, "Contributions of hepatocytes and bile ductular cells in ductular reactions and remodeling of the biliary system after chronic liver injury", Am J Pathol, 184, pp.3001~3012 (2014)
84. Sekiya S, "Hepatocytes, rather than cholangiocytes, can be the major source of primitive ductules in the chronically injured mouse liver", Am J Pathol, 184, pp.1468~1478 (2014)
85. Yimlamai D, "Hippo pathway activity influences liver cell fate", Cell, 157, pp.1324~1338 (2014)
86. Schaub JR, "De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation", Nature, 557, pp.247~251 (2018)
87. Kim M, "DNA methylation in cell plasticity and malignant transformation in liver diseases", Pharmacol Ther, 241, pp.108334~ (2023)
88. Hu S, "NOTCH-YAP1", TEAD-DNMT1axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma, 2022, pp.163, 449~465
89. Liu Y, "Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis", J Hepatol, 76, pp.652~664 (2022)
90. Yoshii D, "SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury", Hum Cell, 35, pp.721~734 (2022)
91. Han X, "Lineage tracing reveals the bipotency of SOX9+ hepatocytes during liver regeneration", Stem Cell Reports, 12, pp.624~638 (2019)
92. Forbes SJ, "Cell therapy for liver disease : from liver transplantation to cell factory", J Hepatol, 62, pp.S157~S169 (2015)
93. Tsolaki E, "Stem cell-based regenerative opportunities for the liver : state of the art and beyond", World J Gastroenterol, 21, pp.12334~12350 (2015)
94. Anantharaju A, "Liver transplantation for alcoholic liver disease", Alcohol Res Health, 27, pp.257~268 (2003)
95. Ko S, "Liver progenitors and adult cell plasticity in hepatic injury and repair : knowns and unknowns", Annu Rev Pathol, 15, pp.23~50 (2020)
96. Alison MR, "Hepatocytes from non-hepatic adult stem cells", Nature, 406, pp.257~ (2000)
97. Huang P, "Direct reprogramming of human fibroblasts to functional and expandable hepatocytes", Cell Stem Cell, 14, pp.370~384 (2014)
98. Lagasse E, "Purified hematopoietic stem cells can differentiate into hepatocytes in vivo", Nat Med, 6, pp.1229~1234 (2000)
99. Snykers S, "Sequential exposure to cytokines reflecting embryogenesis : the key for in vitro differentiation of adult bone marrow stem cells into functional hepatocyte-like cells", Toxicol Sci, 94, pp.330~341 (2006)
100. Bird TG, "Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling", Proc Natl Acad Sci U S A, 110, pp.6542~6547 (2013)
101. Boulter L, "Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease", Nat Med, 18, pp.572~579 (2012)
102. Fallowfield JA, "Scar-associated macrophages are a major source of hepatic matrix metallo proteinase-13 and facilitate the resolution of murine hepatic fibrosis", J Immunol, 178, pp.5288~5295 (2007)
103. Thomas JA, "Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function", Hepatology, 53, pp.2003~2015 (2011)
104. Zhang S, "Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation", Tissue Eng Part A, 18, pp.1352~1364 (2012)
105. Miyoshi T, "Successful induction of human chemically induced liver progenitors with small molecules from damaged liver", J Gastroenterol, 57, pp.441~452 (2022)
106. Stueck AE, "Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis", Hepatology, 61, pp.1696~1707 (2015)
107. Lu WY, "Hepatic progenitor cells of biliary origin with liver repopulation capacity", Nat Cell Biol, 17, pp.971~983 (2015)
108. Susick R, "Hepatic progenitors and strategies for liver cell therapies", Ann N Y Acad Sci, 944, pp.398~419 (2001)
109. Cardinale V, "Transplantation of human fetal biliary tree stem", progenitor cells into two patients with advanced liver cirrhosis, 2014, pp.14, 204~
110. Takayama K, "Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine", Hepatol Commun, 1, pp.1058~1069 (2017)
111. Sampaziotis F, "Cholangiocyte organoids can repair bile ducts after transplantation in the human liver", Science, 371, pp.839~846 (2021)
112. Wang YH, "Mesenchymal stem cell therapy in acute liver failure", Gut Liver, 17, pp.674~683 (2023)

관련 논문AI추천